{"id":"https://openalex.org/W2157296439","doi":"https://doi.org/10.1681/asn.2012020181","title":"Rituximab in Idiopathic Membranous Nephropathy","display_name":"Rituximab in Idiopathic Membranous Nephropathy","publication_year":2012,"publication_date":"2012-07-20","ids":{"openalex":"https://openalex.org/W2157296439","doi":"https://doi.org/10.1681/asn.2012020181","mag":"2157296439","pmid":"https://pubmed.ncbi.nlm.nih.gov/22822077","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3402291"},"language":"en","primary_location":{"id":"doi:10.1681/asn.2012020181","doi":"https://doi.org/10.1681/asn.2012020181","is_oa":false,"landing_page_url":"https://doi.org/10.1681/asn.2012020181","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://europepmc.org/abstract/MED/22822077","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059276594","display_name":"Piero Luigi Ruggenenti","orcid":"https://orcid.org/0000-0002-8394-0879","observed_orcids":["https://orcid.org/0000-0002-8394-0879"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Piero Ruggenenti","raw_affiliation_strings":["Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases, Aldo e Cele Dacc\u00f2, Villa Camozzi, Ranica, Italy","Units of Nephrology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases, Aldo e Cele Dacc\u00f2, Villa Camozzi, Ranica, Italy","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Units of Nephrology and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005075162","display_name":"Paolo Cravedi","orcid":"https://orcid.org/0000-0001-7837-0923","observed_orcids":["https://orcid.org/0000-0001-7837-0923"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Paolo Cravedi","raw_affiliation_strings":["Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases, Aldo e Cele Dacc\u00f2, Villa Camozzi, Ranica, Italy","Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases, Aldo e Cele Dacc\u00f2, Villa Camozzi, Ranica, Italy; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases, Aldo e Cele Dacc\u00f2, Villa Camozzi, Ranica, Italy","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases, Aldo e Cele Dacc\u00f2, Villa Camozzi, Ranica, Italy; and","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040675114","display_name":"Antonietta Chianca","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Antonietta Chianca","raw_affiliation_strings":["Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases, Aldo e Cele Dacc\u00f2, Villa Camozzi, Ranica, Italy","Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases, Aldo e Cele Dacc\u00f2, Villa Camozzi, Ranica, Italy; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases, Aldo e Cele Dacc\u00f2, Villa Camozzi, Ranica, Italy","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases, Aldo e Cele Dacc\u00f2, Villa Camozzi, Ranica, Italy; and","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052434587","display_name":"Annalisa Perna","orcid":"https://orcid.org/0000-0002-9257-0283","observed_orcids":["https://orcid.org/0000-0002-9257-0283"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Annalisa Perna","raw_affiliation_strings":["Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases, Aldo e Cele Dacc\u00f2, Villa Camozzi, Ranica, Italy","Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases, Aldo e Cele Dacc\u00f2, Villa Camozzi, Ranica, Italy; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases, Aldo e Cele Dacc\u00f2, Villa Camozzi, Ranica, Italy","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases, Aldo e Cele Dacc\u00f2, Villa Camozzi, Ranica, Italy; and","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046118830","display_name":"Barbara Ruggiero","orcid":"https://orcid.org/0000-0003-4442-7201","observed_orcids":["https://orcid.org/0000-0003-4442-7201"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Barbara Ruggiero","raw_affiliation_strings":["Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases, Aldo e Cele Dacc\u00f2, Villa Camozzi, Ranica, Italy","Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases, Aldo e Cele Dacc\u00f2, Villa Camozzi, Ranica, Italy; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases, Aldo e Cele Dacc\u00f2, Villa Camozzi, Ranica, Italy","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases, Aldo e Cele Dacc\u00f2, Villa Camozzi, Ranica, Italy; and","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051449033","display_name":"Flavio Gaspari","orcid":"https://orcid.org/0000-0001-5941-3481","observed_orcids":["https://orcid.org/0000-0001-5941-3481"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Flavio Gaspari","raw_affiliation_strings":["Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases, Aldo e Cele Dacc\u00f2, Villa Camozzi, Ranica, Italy","Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases, Aldo e Cele Dacc\u00f2, Villa Camozzi, Ranica, Italy; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases, Aldo e Cele Dacc\u00f2, Villa Camozzi, Ranica, Italy","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases, Aldo e Cele Dacc\u00f2, Villa Camozzi, Ranica, Italy; and","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055401685","display_name":"Alessandro Rambaldi","orcid":"https://orcid.org/0000-0002-3739-7502","observed_orcids":["https://orcid.org/0000-0002-3739-7502"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alessandro Rambaldi","raw_affiliation_strings":["Hematology, Azienda Ospedaliera, Ospedali Riuniti di Bergamo, Bergamo, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology, Azienda Ospedaliera, Ospedali Riuniti di Bergamo, Bergamo, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018028119","display_name":"Maddalena Maras\u00e0","orcid":"https://orcid.org/0000-0003-0712-2329","observed_orcids":["https://orcid.org/0000-0003-0712-2329"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Maddalena Maras\u00e0","raw_affiliation_strings":["Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases, Aldo e Cele Dacc\u00f2, Villa Camozzi, Ranica, Italy","Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases, Aldo e Cele Dacc\u00f2, Villa Camozzi, Ranica, Italy; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases, Aldo e Cele Dacc\u00f2, Villa Camozzi, Ranica, Italy","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases, Aldo e Cele Dacc\u00f2, Villa Camozzi, Ranica, Italy; and","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023556434","display_name":"Giuseppe Remuzzi","orcid":"https://orcid.org/0000-0002-6194-3446","observed_orcids":["https://orcid.org/0000-0002-6194-3446"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Giuseppe Remuzzi","raw_affiliation_strings":["Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases, Aldo e Cele Dacc\u00f2, Villa Camozzi, Ranica, Italy","Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases, Aldo e Cele Dacc\u00f2, Villa Camozzi, Ranica, Italy; and","Units of Nephrology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases, Aldo e Cele Dacc\u00f2, Villa Camozzi, Ranica, Italy","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases, Aldo e Cele Dacc\u00f2, Villa Camozzi, Ranica, Italy; and","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Units of Nephrology and","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5005075162","https://openalex.org/A5018028119","https://openalex.org/A5023556434","https://openalex.org/A5040675114","https://openalex.org/A5046118830","https://openalex.org/A5051449033","https://openalex.org/A5052434587","https://openalex.org/A5059276594"],"corresponding_institution_ids":["https://openalex.org/I19630809"],"apc_list":null,"apc_paid":null,"fwci":19.2655,"has_fulltext":false,"cited_by_count":324,"citation_normalized_percentile":{"value":0.99657051,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"23","issue":"8","first_page":"1416","last_page":"1425"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10697","display_name":"Vasculitis and related conditions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":1.0},{"id":"https://openalex.org/keywords/idiopathic-membranous-nephropathy","display_name":"idiopathic membranous nephropathy","score":0.9990000128746033},{"id":"https://openalex.org/keywords/b-cell-depletion","display_name":"B-cell depletion","score":0.6919999718666077},{"id":"https://openalex.org/keywords/nephrotic-syndrome","display_name":"nephrotic syndrome","score":0.8420000076293945},{"id":"https://openalex.org/keywords/proteinuria","display_name":"proteinuria","score":0.8450000286102295},{"id":"https://openalex.org/keywords/remission","display_name":"remission","score":0.734000027179718},{"id":"https://openalex.org/keywords/glomerular-filtration","display_name":"glomerular filtration","score":0.7170000076293945},{"id":"https://openalex.org/keywords/glomerular-filtration-rate-decline","display_name":"glomerular filtration rate decline","score":0.7710000276565552},{"id":"https://openalex.org/keywords/end-stage-renal-disease","display_name":"end-stage renal disease","score":0.7360000014305115}],"concepts":[{"id":"https://openalex.org/C2779561371","wikidata":"https://www.wikidata.org/wiki/Q570197","display_name":"Proteinuria","level":3,"score":0.88587486743927},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8344348669052124},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.8232108354568481},{"id":"https://openalex.org/C2778930706","wikidata":"https://www.wikidata.org/wiki/Q504790","display_name":"Nephrotic syndrome","level":2,"score":0.652534008026123},{"id":"https://openalex.org/C2775946357","wikidata":"https://www.wikidata.org/wiki/Q1713037","display_name":"Membranous nephropathy","level":4,"score":0.6260721683502197},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6258131265640259},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.5862196087837219},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.568665623664856},{"id":"https://openalex.org/C2776434150","wikidata":"https://www.wikidata.org/wiki/Q1639997","display_name":"Spontaneous remission","level":3,"score":0.49164658784866333},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.43368279933929443},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.35965293645858765},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.22282135486602783},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.1247420608997345},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069283","descriptor_name":"Rituximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005919","descriptor_name":"Glomerular Filtration Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015433","descriptor_name":"Glomerulonephritis, Membranous","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D015433","descriptor_name":"Glomerulonephritis, Membranous","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018655","descriptor_name":"Lymphocyte Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058846","descriptor_name":"Antibodies, Monoclonal, Murine-Derived","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1681/asn.2012020181","doi":"https://doi.org/10.1681/asn.2012020181","is_oa":false,"landing_page_url":"https://doi.org/10.1681/asn.2012020181","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2719412","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/abstract/MED/22822077","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3402291","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3402291","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Am Soc Nephrol","raw_type":"Text"},{"id":"pmid:22822077","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22822077","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology : JASN","raw_type":"Clinical Trial"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:2719412","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/abstract/MED/22822077","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":66,"referenced_works":["https://openalex.org/W137167786","https://openalex.org/W1895721478","https://openalex.org/W1963592300","https://openalex.org/W1965554526","https://openalex.org/W1969467075","https://openalex.org/W1973388794","https://openalex.org/W1975445934","https://openalex.org/W1975736815","https://openalex.org/W1977206110","https://openalex.org/W1977932880","https://openalex.org/W1986167294","https://openalex.org/W1989529519","https://openalex.org/W1990614192","https://openalex.org/W1999494502","https://openalex.org/W2006128988","https://openalex.org/W2009885339","https://openalex.org/W2011309580","https://openalex.org/W2018459774","https://openalex.org/W2018680608","https://openalex.org/W2023720190","https://openalex.org/W2034759249","https://openalex.org/W2041514348","https://openalex.org/W2044080899","https://openalex.org/W2046059252","https://openalex.org/W2046712343","https://openalex.org/W2050071967","https://openalex.org/W2051090119","https://openalex.org/W2052951425","https://openalex.org/W2063470653","https://openalex.org/W2067632847","https://openalex.org/W2073033781","https://openalex.org/W2089916413","https://openalex.org/W2107002794","https://openalex.org/W2108437485","https://openalex.org/W2110482159","https://openalex.org/W2115472834","https://openalex.org/W2116986363","https://openalex.org/W2122581834","https://openalex.org/W2123676752","https://openalex.org/W2127014397","https://openalex.org/W2133344401","https://openalex.org/W2135619376","https://openalex.org/W2137159296","https://openalex.org/W2138612272","https://openalex.org/W2140565611","https://openalex.org/W2141219630","https://openalex.org/W2142377667","https://openalex.org/W2143000096","https://openalex.org/W2148303421","https://openalex.org/W2164755825","https://openalex.org/W2166147255","https://openalex.org/W2166822765","https://openalex.org/W2167795729","https://openalex.org/W2172275967","https://openalex.org/W2264636885","https://openalex.org/W2322148317","https://openalex.org/W2325628725","https://openalex.org/W2326202408","https://openalex.org/W2333857244","https://openalex.org/W2396051933","https://openalex.org/W2407867937","https://openalex.org/W2414421915","https://openalex.org/W2440927393","https://openalex.org/W2461760011","https://openalex.org/W2467207641","https://openalex.org/W6680509875"],"related_works":["https://openalex.org/W2531027919","https://openalex.org/W7133168123","https://openalex.org/W2018459774","https://openalex.org/W3087681045","https://openalex.org/W2728745795","https://openalex.org/W2769536415","https://openalex.org/W3202583820","https://openalex.org/W2319481643","https://openalex.org/W2792454235","https://openalex.org/W2111892488"],"abstract_inverted_index":{"Selective":[0],"depletion":[1],"of":[2,67,97,105,172,177,209],"B":[3],"cells":[4],"with":[5,29,33,111,182,212],"the":[6,11,164,170,175],"mAb":[7],"rituximab":[8,71,195],"may":[9],"benefit":[10],"autoimmune":[12],"glomerular":[13],"disease":[14,197],"idiopathic":[15],"membranous":[16],"nephropathy":[17],"(IMN).":[18],"Here,":[19],"we":[20],"describe":[21],"our":[22],"experience":[23],"treating":[24],"100":[25],"consecutive":[26],"IMN":[27],"patients":[28,74,90,110,118,211],"persistent":[30,40,49],"nephrotic":[31],"syndrome":[32],"rituximab.":[34],"We":[35],"defined":[36],"complete":[37,76,100,142,156],"remission":[38,47,84,106,198],"as":[39,48],"proteinuria":[41,50,60,178],"<0.3":[42],"g/24":[43,52],"h":[44],"and":[45,120,148,163,199],"partial":[46,78,102,158],"<3":[51],"h,":[53],"each":[54,167],"also":[55],"having":[56],">50%":[57],"reduction":[58,179],"in":[59,205],"from":[61],"baseline.":[62],"During":[63],"a":[64,129,206],"median":[65,81],"follow-up":[66,98,165],"29":[68],"months":[69],"after":[70],"administration,":[72],"65":[73],"achieved":[75,99,141,196],"or":[77,101,112,157,201],"remission.":[79,103,143,159],"The":[80],"time":[82],"to":[83,123],"was":[85],"7.1":[86],"months.":[87],"All":[88],"24":[89],"who":[91,140],"had":[92],"at":[93,161],"least":[94],"4":[95],"years":[96],"Rates":[104],"were":[107],"similar":[108],"between":[109],"without":[113],"previous":[114],"immunosuppressive":[115],"treatment.":[116],"Four":[117],"died":[119],"four":[121],"progressed":[122],"ESRD.":[124],"Measured":[125],"GFR":[126,184],"increased":[127,147],"by":[128],"mean":[130],"13.2":[131],"(SD":[132],"19.6)":[133],"ml/min":[134],"per":[135],"1.73":[136],"m(2)":[137],"among":[138,153],"those":[139,154],"Serum":[144],"albumin":[145,149],"significantly":[146,180],"fractional":[150],"clearance":[151],"decreased":[152],"achieving":[155],"Proteinuria":[160],"baseline":[162],"duration":[166],"independently":[168],"predicted":[169],"decline":[171,185],"proteinuria.":[173],"Furthermore,":[174],"magnitude":[176],"correlated":[181],"slower":[183],"(P=0.0001).":[186],"No":[187],"treatment-related":[188],"serious":[189],"adverse":[190],"events":[191],"occurred.":[192],"In":[193],"summary,":[194],"stabilized":[200],"improved":[202],"renal":[203],"function":[204],"large":[207],"cohort":[208],"high-risk":[210],"IMN.":[213]},"counts_by_year":[{"year":2026,"cited_by_count":18},{"year":2025,"cited_by_count":24},{"year":2024,"cited_by_count":20},{"year":2023,"cited_by_count":27},{"year":2022,"cited_by_count":18},{"year":2021,"cited_by_count":26},{"year":2020,"cited_by_count":17},{"year":2019,"cited_by_count":23},{"year":2018,"cited_by_count":16},{"year":2017,"cited_by_count":25},{"year":2016,"cited_by_count":28},{"year":2015,"cited_by_count":22},{"year":2014,"cited_by_count":27},{"year":2013,"cited_by_count":28},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}